One of two divisions does not hold
Both product pages use the same layout: a question about paying monthly instead of quarterly, a per-month figure, the words quarterly plan, and the amount billed today. On the tirzepatide page the per-month figure multiplied by three gives the quarterly charge exactly.
On the semaglutide page it does not. Multiplying the printed monthly figure by three produces a smaller number than the seller says it will take. The gap is a few dollars, which is small enough to pass every eye and large enough to prove nobody checked.
We have recorded both rows as not monthly, carrying the amount actually charged, with the arithmetic set out in the qualifier. A per-month figure a seller cannot reproduce from its own billing is not a monthly rate.
What the charge covers
Both pages list the medication, a provider evaluation and discreet delivery as included, and state that no insurance is required. Neither says anything about a membership, so we have recorded that position as unstated.
There is no dose ladder behind either figure and no indication of what a higher strength costs, which is the usual gap on a flat quarterly plan.
No terms page, and a host that hides that fact
Two conventional paths for a terms-of-service document were requested. Both returned a not-found status. No operating entity could be found anywhere on the pages that do exist.
That not-found response is byte-identical to a nonsense-path control run against the same host in the same session — same status, same size, same body. On this host, only the status code separates a page that exists from an address invented on the spot.
That is worth recording because a check that verified a URL by its response size would confirm any address at all on this domain. No compounding pharmacy is named and no service area is published.
10Rx's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $299billed $299 today on a quarterly plan; the seller prints "$96.67 per month" beside it, but $299 divided by three is $99.67, so its own monthly equivalent is three dollars short of what it charges | September 2026source |
| Tirzepatide (compounded) | $449billed $449 today on a quarterly plan; here the seller prints $149.67 a month, which divides correctly - the arithmetic is right on this page and wrong on the semaglutide one | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 158 providers reviewed here are paid partners today; the other 154 are not. See how this works.
See 10Rx's current price →Good fit if
- Buyers who prefer one quarterly charge to a monthly subscription.
- Readers who want the amount actually billed printed beside the per-month equivalent.
- People who will check a seller's arithmetic rather than trust it.
Look elsewhere if
- Anyone who wants a legal entity named; none could be found.
- Buyers who want a dose ladder rather than a single flat figure.
- Readers who need a service-area list or a named pharmacy.
- People who want a terms document to read before buying.
How this review was verified
- Read both product pages on 6 September 2026 and requested two conventional terms paths, with a nonsense-path control on the host in the same run.
- Recorded that the terms not-found response and the nonsense control returned identical status, size and body, so nothing on this host was judged by response size.
- Multiplied each printed monthly figure by three and compared it against the seller's own stated quarterly charge, rather than repeating either number.
- Screened the operating entity and the brand name against FDA's live warning-letter datatable, carrying a known letter as a positive control and a nonsense string as a negative control in the same pass; the positive control returned its letter and the negative returned nothing. Neither the entity nor the brand returned one. Untitled letters are published separately and were not searched, so the supportable claim is that no warning letter was found.